Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-16 Hopkinson Craig C. EVP R&D, Chief Medical Officer Shares withheld for taxes −1,172 $17.77 $21K 9,080
2020-02-16 Hopkinson Craig C. EVP R&D, Chief Medical Officer Exercise or conversion · Restricted Stock Unit Award −3,375 6,750
2020-02-16 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Exercise or conversion +3,375 51,925
2020-02-16 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Shares withheld for taxes −1,172 $17.77 $21K 50,753
2020-02-16 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Exercise or conversion · Restricted Stock Unit Award −3,375 6,750
2020-02-16 FRATES JAMES M SVP, Alks Inc; CFO ALKS Exercise or conversion +3,375 61,631
2020-02-16 FRATES JAMES M SVP, Alks Inc; CFO ALKS Shares withheld for taxes −1,172 $17.77 $21K 60,459
2020-02-16 FRATES JAMES M SVP, Alks Inc; CFO ALKS Exercise or conversion · Restricted Stock Unit Award −3,375 6,750
2020-02-16 Brown Iain Michael SVP Finance & CAO, Alks Inc. Exercise or conversion +2,375 32,777
2020-02-16 Brown Iain Michael SVP Finance & CAO, Alks Inc. Shares withheld for taxes −825 $17.77 $15K 31,952
2020-02-16 Brown Iain Michael SVP Finance & CAO, Alks Inc. Exercise or conversion · Restricted Stock Unit Award −2,375 4,750
2019-12-04 Wilson Frank Anders Director Grant or award · Non Qualified Stock Option (Right to Buy) +11,200 11,200
2019-12-04 Wilson Frank Anders Director Grant or award · Non Qualified Stock Option (Right to Buy) +61,800 61,800
2019-12-04 GAYNOR RICHARD Director Grant or award · Non Qualified Stock Option (Right to Buy) +11,200 11,200
2019-12-04 GAYNOR RICHARD Director Grant or award · Non Qualified Stock Option (Right to Buy) +61,800 61,800
2019-11-14 POPS RICHARD F Director and CEO, Alkermes plc Exercise or conversion +100,000 $9.21 $921K 816,433
2019-11-14 POPS RICHARD F Director and CEO, Alkermes plc Sale −100,000 $19.50 $1.9M 716,433
2019-11-14 POPS RICHARD F Director and CEO, Alkermes plc Exercise or conversion · Employee Stock Option (Right to Buy) −100,000 0
2019-11-13 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Exercise or conversion +20,000 $9.21 $184K 205,122
2019-11-13 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Sale −20,000 $19.70 $394K 185,122

Page 78 of 90 · 1,796 trades